Home / Health / Psychedelic Retreats Boom: Healing or High Risk?
Psychedelic Retreats Boom: Healing or High Risk?
20 Apr
Summary
- Psychedelic retreats are proliferating globally, offering drug-assisted experiences for mental health.
- Most psychedelics used are illegal in the US, with few legal exemptions for retreats.
- Experts warn of unregulated safety, inconsistent screening, and risky medication withdrawal practices.
The growing fascination with the therapeutic potential of psychedelic drugs has spurred the creation of numerous psychedelic retreats globally. These establishments offer multiday experiences with the promise of psychological healing and personal development. Despite some implementing safety measures, researchers highlight significant risks, including potential physical and psychological harm.
In the United States, the substances commonly offered at these retreats, such as magic mushrooms and LSD, are illegal. Some retreat companies exploit a narrow religious exemption, but few have secured this legal status. Many operations are based in countries like Peru and Brazil, where certain psychedelics have traditional uses. However, there is a notable absence of universal safety standards or regulations governing participant care.
Concerns are mounting regarding the inconsistent screening processes for participants, with many retreats failing to rigorously assess individuals with serious medical or mental health conditions. Experts emphasize that psychedelic drugs can exacerbate symptoms of psychotic disorders, underscoring the need for careful patient vetting. Additionally, a significant majority of retreats require attendees to discontinue crucial medications, like antidepressants, without adequate medical guidance, posing risks of symptom recurrence or exacerbation.
